TARSyn: Tunable Antibiotic Resistance Devices Enabling Bacterial Synthetic Evolution and Protein Production

ACS Synth Biol. 2018 Feb 16;7(2):432-442. doi: 10.1021/acssynbio.7b00200. Epub 2018 Jan 4.

Abstract

Evolution can be harnessed to optimize synthetic biology designs. A prominent example is recombinant protein production-a dominating theme in biotechnology for more than three decades. Typically, a protein coding sequence (cds) is recombined with genetic elements, such as promoters, ribosome binding sites and terminators, which control expression in a cell factory. A major bottleneck during production is translational initiation. Previously we identified more effective translation initiation regions (TIRs) by creating sequence libraries and then selecting for a TIR that drives high-level expression-an example of synthetic evolution. However, manual screening limits the ability to assay expression levels of all putative sequences in the libraries. Here we have solved this bottleneck by designing a collection of translational coupling devices based on a RNA secondary structure. Exchange of different sequence elements in this device allows for different coupling efficiencies, therefore giving the devices a tunable nature. Sandwiching these devices between the cds and an antibiotic selection marker that functions over a broad dynamic range of antibiotic concentrations adds to the tunability and allows expression levels in large clone libraries to be probed using a simple cell survival assay on the respective antibiotic. The power of the approach is demonstrated by substantially increasing production of two commercially interesting proteins, a Nanobody and an Affibody. The method is a simple and inexpensive alternative to advanced screening techniques that can be carried out in any laboratory.

Keywords: antibiotic resistance; protein production; selection system; synthetic evolution; translation initiation region; translational coupling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Directed Molecular Evolution / methods*
  • Drug Resistance, Bacterial*
  • Escherichia coli* / genetics
  • Escherichia coli* / metabolism
  • Nucleic Acid Conformation*
  • Peptide Chain Initiation, Translational / genetics*
  • RNA, Bacterial* / genetics
  • RNA, Bacterial* / metabolism
  • Recombinant Proteins / blood
  • Recombinant Proteins / genetics
  • Single-Domain Antibodies* / biosynthesis
  • Single-Domain Antibodies* / genetics

Substances

  • RNA, Bacterial
  • Recombinant Proteins
  • Single-Domain Antibodies